A
Anne M. Audelin
Researcher at Statens Serum Institut
Publications - 8
Citations - 209
Anne M. Audelin is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Drug resistance & Cohort study. The author has an hindex of 6, co-authored 8 publications receiving 191 citations.
Papers
More filters
Journal ArticleDOI
HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
Joakim Esbjörnsson,Joakim Esbjörnsson,Joakim Esbjörnsson,Mattias Mild,Anne M. Audelin,Jannik Fonager,Helena Skar,Louise B. Jørgensen,Kirsi Liitsola,Per Björkman,Göran Bratt,Magnus Gisslén,Anders Sönnerborg,Anders Sönnerborg,Claus Nielsen,Esar Programme,Patrik Medstrand,Patrik Medstrand,Jan Albert +18 more
TL;DR: Different HIV-1 transmission patterns between countries and transmission groups in a large geographical region are described and may have implications for public health interventions in targeting HIV- 1 transmission networks and identifying where to introduce such interventions.
Journal ArticleDOI
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia.
Alemseged Abdissa,Alemseged Abdissa,Daniel Yilma,Jannik Fonager,Anne M. Audelin,Lone H Christensen,Mette F Olsen,Markos Tesfaye,Pernille Kæstel,Tsinuel Girma,Abraham Aseffa,Henrik Friis,Court Pedersen,Aase B. Andersen +13 more
TL;DR: The data confirm that the currently recommended first-line ART regimen is efficient in the vast majority of individuals initiating therapy in Jimma, Ethiopia eight years after the introduction of ART, and underlines the need for rapid, inexpensive tests to identify the most common drug resistance mutations.
Journal ArticleDOI
Phylogenetics of the Danish HIV epidemic: the role of very late presenters in sustaining the epidemic.
TL;DR: Danish HIV epidemic is driven mainly by younger homosexual men diagnosed during primary HIV infection, mainly consisted of Danish individuals with homosexual and intravenous drug use risk behavior, infected in Denmark with subtype B.
Journal ArticleDOI
The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.
TL;DR: The incidence of acquired drug resistance has decreased among HIV-infected patients treated with HAART in Denmark during 1999-2005, and the IRs were low for specific resistance mutations, except for M184V.
Journal ArticleDOI
Molecular Phylogenetics of Transmitted Drug Resistance in Newly Diagnosed HIV Type 1 Individuals in Denmark, a Nation-Wide Study
Anne M. Audelin,Jan Gerstoft,Niels Obel,Lars Mathiesen,Alex Lund Laursen,Court Pedersen,Henrik Nielsen,Janne Jensen,Lars Peter Nielsen,Claus J. Nielsen,Louise B. Jørgensen +10 more
TL;DR: Virus from 1405 individuals diagnosed with HIV-1 in Denmark between 2001 and 2009 was analyzed for TDR, and molecular-epidemiological links and progression of the infection were described based on data from standardized questionnaires, the prospective Danish HIV Cohort Study, and by phylogenetic analysis.